Showing results (141-150 of 559) with videos related to
Sort By:
Pageof 56
Circulation|January 31, 2016
Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)Marc P Bonaca, J Antonio Gutierrez, Mark A Creager, et al.Journal of the American College of Cardiology|October 8, 2021
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-ITKazuma Oyama, Robert P Giugliano, Michael A Blazing, et al.Journal of the American College of Cardiology|October 2, 2002
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromesNeal S Kleiman, Nasser Lakkis, Christopher P Cannon, et al.Circulation. Heart Failure|February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF TrialDavid D Berg, Marc D Samsky, Eric J Velazquez, et al.International Journal of Cardiology|January 12, 2008
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromesShaheeda Ahmed, Christopher P Cannon, Robert P Giugliano, et al.European Heart Journal. Cardiovascular Pharmacotherapy|October 16, 2020
Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trialsAnna Plitt, Thomas A Zelniker, Jeong-Gun Park, et al.Circulation. Heart Failure|May 4, 2016
Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart FailureGregory D Lewis, Marc J Semigran, Michael M Givertz, et al.European Journal of Preventive Cardiology|February 24, 2021
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndromeBaris Gencer, David A Morrow, Eugene Braunwald, et al.Journal of the American Heart Association|October 30, 2018
Cystatin C for Risk Stratification in Patients After an Acute Coronary SyndromeSimon Correa, David A Morrow, Eugene Braunwald, et al.JACC. Cardiovascular Interventions|August 21, 2010
Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudyYuri B Pride, Patricia Tung, Satishkumar Mohanavelu, et al.Pageof 56